Pharming (PHAR) Return on Equity [ROE] (2021 - 2026)
Pharming (PHAR) recorded Return on Equity [ROE] of -3.12% in Q3 2026, up 1.92 percentage points from -5.05% a year earlier and up 0.13 percentage points from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Pharming reported Return on Equity [ROE] of 1.02%, up 7.70 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -24.08 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -6.68% in FY2024 (-1.70 pp), -4.98% in FY2023 (-19.22 pp), 14.24% in FY2022 (+5.74 pp) and 8.50% in FY2021 (-16.59 pp).
- The Q3 2026 figure is the highest quarterly Return on Equity [ROE] since Q1 2024.
- On a year-over-year basis, Return on Equity [ROE] has increased for six consecutive quarters, with an average year-over-year change of +0.67 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 20.30 percentage points in Q3 2022, against a drop of 52.97 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -3.25% (Q2 2026), -5.69% (Q1 2026) and -6.43% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Pharming | 927.62 Mn | 229.29 Mn | 102.20 | -3.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3.13% |
| Jun 30, 2026 | -3.26% |
| Mar 31, 2026 | -5.70% |
| Dec 31, 2025 | -6.43% |
| Sep 30, 2025 | -5.05% |
| Jun 30, 2025 | -5.36% |
| Mar 31, 2025 | -8.34% |
| Dec 31, 2024 | -7.69% |
| Sep 30, 2024 | -8.56% |
| Jun 30, 2024 | -7.35% |
| Mar 31, 2024 | -3.09% |
| Dec 31, 2023 | -4.92% |
| Sep 30, 2023 | -10.74% |
| Jun 30, 2023 | -8.21% |
| Mar 31, 2023 | -0.99% |
| Dec 31, 2022 | 13.38% |
| Sep 30, 2022 | 42.23% |
| Jun 30, 2022 | 16.65% |
| Mar 31, 2022 | 23.61% |
| Dec 31, 2021 | 28.83% |
API Access
Pharming Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();